This company operates in a completely different space than Facebook, but while other companies are postponing their IPO’s or withdrawing them all together, one is still looking to start trading this week. Maybe because the offering is so small there will still be plenty of available capital to participate in the IPO. It hopes to raise $48 million, giving the company a total market cap of $111.9 million. The deal is underwritten by William Blair & Company, Baird, Needham & Company, and First Analysis Securities Corporation. Cancer Genetics (CGIX) is pricing 4 million shares at $1…..Read The Full Article Here